Top 5 Crowdfunding VC Funds & Investors in Germany (July 2026)

Portfolio highlights

• Blips — Blips is a platform in Brazil that aims to bridge the gap between investors and entrepreneurs. The company connects and drives investors and entrepreneurs with tangible assets that enable productive business activities, allowing customers to buy and finance supplies and inputs, as well as an educational platform to support the entrepreneurs'journey, teaching management techniques, growth, and technical knowledge for equipment use.
• First AML — Get AML/CTF compliant and solve your toughest AML challenges with First AML. It's the only AML & KYC software solution you need.
• Honeycomb — Honeycomb is a software debugging tool that can help you solve problems faster within your distributed services. Try Honeycomb for free today!

Portfolio highlights

• Exporo — Exporo offers investors an overview of real estate projects in which they can invest easily, transparently and free of charge.The idea begins in 2013 with the realization that real estate project developers are increasingly looking for alternative sources of finance, as banks no longer finance entire projects as usual due to stricter regulation,and that private investors only have a lot of money, with good conditions and easy to invest in real estate. The result of this observation is the firm decision to develop its own online marketplace to offer real estate projects as an investment opportunity and to provide capital directly between private investors and real estate companies.Simon Brunke, Björn Maronde, Tim Bütecke and Julian Oertzen founded the online platform in 2014, they are constantly evolving and they are board members of Exporo AG. The company now employs more than 120 people and is based in Hamburg's HafenCity.
• Perk (formerly TravelPerk) — TravelPerk offers the freedom travelers want, and the control companies need. Enjoy an industry-leading travel inventory, 24/7 support and easy booking.
• Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.

Portfolio highlights

• Exein — The firmware security software and middleware can be injected like a vaccine in the hardware and aims to defend it from inside, working directly into the firmware at a lower level.
• Isar Aerospace — Isar Aerospace is a space technology company that builds rockets in an automated production. It offers launch services dedicated to deploying and resupplying satellite constellations and to ensure low-cost space access for small satellites. The company was founded in 2018 in Europe.
• Fifth Dimension AI — Boost your productivity with our AI Assistant for property professionals. Supercharge your real estate teams across investment, asset management, research, and marketing.

Portfolio highlights

• INXM — INXM develops Orchestrator, a process execution engine that turns user intent into executable workflows for enterprises.
• encosa —
• &Charge — &Charge is your e-mobility platform which rewards your activities and shopping trips with free energy for your electric car.

Portfolio highlights

• AYOXXA — AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer,allergies, cardiovascular and infectious diseases – in a single test.
• SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
• CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.